{"id":"https://openalex.org/W2000674592","doi":"https://doi.org/10.1002/jps.10190","title":"Distribution, Metabolism, and Excretion of a Novel Surface\u2010Active Agent, Purified Poloxamer 188, in Rats, Dogs, and Humans","display_name":"Distribution, Metabolism, and Excretion of a Novel Surface\u2010Active Agent, Purified Poloxamer 188, in Rats, Dogs, and Humans","publication_year":2002,"publication_date":"2002-09-01","ids":{"openalex":"https://openalex.org/W2000674592","doi":"https://doi.org/10.1002/jps.10190","mag":"2000674592","pmid":"https://pubmed.ncbi.nlm.nih.gov/12210041"},"language":"en","primary_location":{"id":"doi:10.1002/jps.10190","doi":"https://doi.org/10.1002/jps.10190","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.10190","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042612599","display_name":"Joseph M. Grindel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I909123340","display_name":"CytRx (United States)","ror":"https://ror.org/02m8d5f73","country_code":"US","type":"company","lineage":["https://openalex.org/I909123340"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"J. Michael Grindel","raw_affiliation_strings":["CytRx Corporation, 154 Technology Parkway, Suite 200, Norcross, Georgia 30092, USA. grindelm@cytrx.com","CytRx Corporation, 154 Technology Parkway, Suite 200, Norcross, Georgia 30092"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CytRx Corporation, 154 Technology Parkway, Suite 200, Norcross, Georgia 30092, USA. grindelm@cytrx.com","institution_ids":["https://openalex.org/I909123340"]},{"raw_affiliation_string":"CytRx Corporation, 154 Technology Parkway, Suite 200, Norcross, Georgia 30092","institution_ids":["https://openalex.org/I909123340"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013507965","display_name":"Ted Jaworski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296342797","display_name":"Pharmaceutical Product Development (United States)","ror":"https://ror.org/01sjx9496","country_code":"US","type":"company","lineage":["https://openalex.org/I1296342797"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ted Jaworski","raw_affiliation_strings":["PPD Development, 3900 Paramount Parkway, Morrisville, North Carolina 27560"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PPD Development, 3900 Paramount Parkway, Morrisville, North Carolina 27560","institution_ids":["https://openalex.org/I1296342797"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063188410","display_name":"Olga N. Piraner","orcid":"https://orcid.org/0000-0001-9705-7297","observed_orcids":["https://orcid.org/0000-0001-9705-7297"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olga Piraner","raw_affiliation_strings":["Center for Disease Control, 4770 Buford Highway, Atlanta, Georgia 30341"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Disease Control, 4770 Buford Highway, Atlanta, Georgia 30341","institution_ids":["https://openalex.org/I1289490764"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Martin Emanuele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I909123340","display_name":"CytRx (United States)","ror":"https://ror.org/02m8d5f73","country_code":"US","type":"company","lineage":["https://openalex.org/I909123340"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Martin Emanuele","raw_affiliation_strings":["CytRx Corporation, 154 Technology Parkway, Suite 200, Norcross, Georgia 30092"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CytRx Corporation, 154 Technology Parkway, Suite 200, Norcross, Georgia 30092","institution_ids":["https://openalex.org/I909123340"]}]},{"author_position":"last","author":{"id":null,"display_name":"M. Balasubramanian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Balasubramanian","raw_affiliation_strings":["Innoconcepts, 750 Brookfield Parkway, Roswell, Georgia 30075"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innoconcepts, 750 Brookfield Parkway, Roswell, Georgia 30075","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5042612599"],"corresponding_institution_ids":["https://openalex.org/I909123340"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":1.2398,"has_fulltext":false,"cited_by_count":120,"citation_normalized_percentile":{"value":0.75942156,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"91","issue":"9","first_page":"1936","last_page":"1947"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.21060000360012054,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.21060000360012054,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.17499999701976776,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10721","display_name":"Surfactants and Colloidal Systems","score":0.10890000313520432,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/poloxamer-188","display_name":"poloxamer 188","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8840000033378601},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9340000152587891},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.6850000023841858},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.7940000295639038},{"id":"https://openalex.org/keywords/excretion","display_name":"excretion","score":0.6859999895095825},{"id":"https://openalex.org/keywords/hemorheology","display_name":"hemorheology","score":0.7620000243186951},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.8740000128746033},{"id":"https://openalex.org/keywords/vaso-occlusive-crisis","display_name":"vaso-occlusive crisis","score":0.9399999976158142},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5440000295639038},{"id":"https://openalex.org/keywords/cross-species-comparison","display_name":"cross-species comparison","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6022987365722656},{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.5912245512008667},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.5650854706764221},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5443754196166992},{"id":"https://openalex.org/C2779720271","wikidata":"https://www.wikidata.org/wiki/Q179422","display_name":"Lymph","level":2,"score":0.5371933579444885},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5165185332298279},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.4870038628578186},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.4355795979499817},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.4201759696006775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4003564119338989},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26674264669418335},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22252124547958374},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.18648898601531982},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.17457565665245056},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002250","descriptor_name":"Carbon Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002850","descriptor_name":"Chromatography, Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013501","descriptor_name":"Surface-Active Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013501","descriptor_name":"Surface-Active Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020442","descriptor_name":"Poloxamer","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D020442","descriptor_name":"Poloxamer","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/jps.10190","doi":"https://doi.org/10.1002/jps.10190","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.10190","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:12210041","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12210041","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W16647783","https://openalex.org/W145908797","https://openalex.org/W1812182671","https://openalex.org/W1910184631","https://openalex.org/W1988372966","https://openalex.org/W2004212811","https://openalex.org/W2022382730","https://openalex.org/W2035632394","https://openalex.org/W2039340383","https://openalex.org/W2039456785","https://openalex.org/W2046692857","https://openalex.org/W2059543403","https://openalex.org/W2084340730","https://openalex.org/W2150520883","https://openalex.org/W2152035302","https://openalex.org/W2157736842","https://openalex.org/W2161921951","https://openalex.org/W2321220512","https://openalex.org/W2338946530","https://openalex.org/W2343178720","https://openalex.org/W2409343132","https://openalex.org/W2904786466","https://openalex.org/W6638444675","https://openalex.org/W6699983173","https://openalex.org/W6703882368","https://openalex.org/W6703959419"],"related_works":["https://openalex.org/W2083431591","https://openalex.org/W2409343132","https://openalex.org/W7099288016","https://openalex.org/W1983898741","https://openalex.org/W1961098356","https://openalex.org/W2008195781","https://openalex.org/W2889092460","https://openalex.org/W2383786133","https://openalex.org/W2158324764","https://openalex.org/W3034098147"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}